Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct.
Haleon has initiated a voluntary nationwide recall of four lots of Gas-X Extra Strength Softgels (125mg, 120 ct. and 72 ct.) due to potential contamination with a diluted propylene glycol-based substance.
This recall affects Haleon, retail distributors, and consumers who purchased the specified Gas-X lots distributed around April 13, 2026.
The presence of an unintended substance in a consumer drug product suggests a potential deviation in manufacturing or raw material quality control. While the source does not detail specific health risks or the nature of the propylene glycol-based substance, such contamination events typically require a thorough investigation into the source of the impurity and a review of supplier quality management systems.
QA and supply chain teams should immediately verify if affected lots are in inventory, quarantine if necessary, and ensure that the recall communication reaches the consumer level as per the voluntary recall strategy. Regulatory teams should document the contamination event in their post-market surveillance records.
WARREN, N.J., June 4, 2026 — Haleon (NYSE: HLN) is voluntarily recalling four lots of Gas-X Extra Strength Softgels 125mg, 120 ct. and 72 ct. distributed on or about April 13, 2026 to the consumer level. The lots are being recalled due to potential contamination with a diluted propylene glycol-based
Open in openFDA / FDA.gov